99cde005743301c47f8fc12053c0e653.ppt
- Количество слайдов: 23
2008년 대한약학회 가을 국제학술대회 프로그램 일시 : 2008년 10월 23일(목) - 24일(금) 장소 : 호텔 서울교육문화회관 ※ 업데이트 되는 학술대회 프로그램 및 자세한 내용은 학회 홈페이지(www. psk. or. kr)에서 확인하실 수 있습니다.
October 23 (Thursday), 2008 Guhmoongo Hall A Guhmoongo Hall B Guhmoongo Hall C Geumgang Hall Gayageum Hall Registration 8: 00 - 9: 00 S 1 9: 00 – 12: 00 Hangang Hall Progress of Intelligent Drug Delivery Systems S 2 S 3 Microbial Infection and Protection S 4 S 5 P 1 Molecular Mechanism and Drug Delivery Development of Target. Based Herbal Prescription Drug Repositioning: Emerging Paradigm for New Drug Discovery Poster: D 4, E 1, E 2, E 3, F 1, F 2 F 3, F 4 Posting: 9: 00~12: 00 Standing: 10: 30~11: 30 12: 00 – 13: 00 Luncheon 13: 00 – 13: 40 Plenary Lecture- Ⅰ(Dr. Thomas Kensler): Guhmoongo Hall C S 6 13: 40 – 16: 40 New Concepts in Pathophysiology and Therapeutics S 7 S 8 Recent Issues of Toxicological Recent Progress in the Strategy for Research in Pharmaceutical Cancer & Cosmetic Chemoprevention Industry S 9 S 10 Recent Trends of Drug Evaluation Pharmaceutical Quality Assurance and Validation 16: 40 – 17: 20 Award Lecture : Guhmoongo Hall C 17: 20 – 18: 30 General Assembly : Guhmoongo Hall C 18: 30 – 20: 00 Reception & Gala Dinner (Hall A & B) P 2 Poster: A 1, A 2, A 4, B 1, B 2 Posting: 13: 30~17: 00 Standing: 15: 30~16: 30
October 24 (Friday), 2008 May 2 (Friday), 2008 Guhmoongo Hall A Guhmoongo Hall B Guhmoongo Hall C Hangang Hall Geumgang Hall Gayageum Hall Registration 8: 00 - 9: 00 S 11 9: 00 – 12: 00 S 12 S 13 S 14 S 15 P 3 Recent Progress in Biochemical Therapeutics Targeting Biomolecules Strategies for the Development of Novel Antidiabetic Agents Korea-Japan Joint Symposium on Reactive Oxygen Species Strategies for Development of Products with Innovative Technology Managed Care Pharmacy Issues for the Better Pharmaceutical Care Poster: D 1, D 2, D 3 Posting: 9: 00~12: 00 Standing: 10: 30~11: 30 12: 00 – 13: 20 Luncheon 13: 20 – 14: 00 Plenary Lecture -Ⅱ(Dr. Tetsuo Nagano): Guhmoongo Hall C S 16 14: 00 – 17: 00 – Current Issues in the Development and Regulation of Biologics S 17 S 18 S 19 S 20 P 4 Technologies for Production of Biological Therapeutics Current Status and Perspectives of Continuing Education for Physicians and Pharmacists On Education and Research Outlook for Social Pharmacy in Korea Drug Metabolism and Transport in Drug Discovery/ Development Poster: A 3, B 4, C 1, C 2, C 3 Posting: 13: 30~17: 00 Standing: 15: 30~16: 30 Closing
Symposium 1 : Progress of Intelligent Drug Delivery Systems Guhmoongo Hall A Organizers : Soo-Chang Song (Korea Institute of Science and Technology) Yu-Kyoung Oh (Korea University) Chairs : S 1 -1 (9: 00 -9: 10) S 1 -2 (9: 10 -09: 35) Soo-Chang Song (Korea Institute of Science and Technology) Kang Choon Lee (Sungkyunkwan University) Overview of intelligent drug delivery system research cluster Soo-Chang Song (Korea Institute of Science and Technology) Trials of novel solid dispersion system of poorly water-soluble drugs with aqueous solution Han-Gon Choi (Yeungnam University) S 1 -3 (09: 35 -10: 00) Delivery of RNA-based therapeutics Yu-Kyoung Oh (Korea University) S 1 -4 (10: 00 -10: 25) VEGF-loaded polymeric nanoparticles for the treatment of ischemic damage Soon Hong Yuk (Hannam University) Coffee Break (10: 25 -10: 35) S 1 -5 (10: 35 -11: 00) Degradable poly(amino ester)s for DNA and si. RNA delivery in vitro and in vivo Chong-Su Cho (Seoul National University) S 1 -6 (11: 00 -11: 25) Tumor specific nanoparticles for imaging and therapy Ick Chan Kwon (Korea Institute of Science and Technology) S 1 -7 (11: 25 -11: 50) Antiapoptotic fusion protein delivery systems Yong-Hee Kim (Hanyang University)
Symposium 2 : Microbial Infection and Protection Guhmoongo Hall B Organizer : Jin Cheol Yoo (Chosun University) Chairs : Bok Yun Kang (Chonnam National University) Dong-Kwon Rhee (Sungkyunkwan University) S 2 -1 (9: 00 -9: 40) S 2 -2 (9: 40 -10: 20) A novel cardiovascular protective agent from plant resources: balance between ROS and NO Min-Ho Oak (Yang. Ji Chemicals) The functional role of H 2 -M 3 during bacterial infection Taehoon Chun (Korea University) Coffee Break (10: 20 -10: 40) S 2 -3 (10: 40 -11: 20) Design, operations and cleanliness of pharmaceutical plants Gernod Dittel (Dittel and University of Applied Sciences Rosenheim, Germany) S 2 -4 (11: 20 -12: 00) Interrelation between quorum sensing and Pseudomonas quinolone signal (PQS) biosynthesis in Pseudomonas aeruginosa Joon-Hee Lee (Pusan National University)
Symposium 3 : Molecular Mechanism and Drug Delivery Guhmoongo Hall C Organizer : Beom-Jin Lee (Kangwon National University) Chairs : Eun Seok Park (Sungkyunkwan University) Hoo-Kyun Choi (Chosun University) S 3 -1 (09: 00 -09: 40) Structure and protein-protein interaction of Helicobacter pylori proteins Bong Jin Lee (Seoul National University) S 3 -2 (09: 40 -10: 20) The structures and function of importin-β Soo Jae Lee (Chungbuk National University) Coffee Break (10: 20 -10: 40) S 3 -3 (10: 40 -11: 20) A combined chemoimmunotherapy approach using a plasmid-doxorubicin complex Sangyong Jon (Gwangju Institute of Science and Technology) S 3 -4 (11: 20 -11: 50) Development of herbal medicine on hepatic fibrosis from Salvia miltiorrhiza through pharmaceutical standardization Dong Hwan Sohn (Wonkwang University)
Symposium 4 : Development of Target-Based Herbal Prescription Hangang Hall Organizer : Sook Yeon Lee (Sahmyook University) Chair : Jong Hoon Ryu (Kyung Hee University) S 4 -1 (9: 00 -9: 30) S 4 -2 (9: 30 -10: 00) Practical use and drug development for Alzheimer’s disease from multi-herbal drug combinationas (LMK 02) Hyung Won Kang (Wonkwang University ) Anti-inflammatory effect of chungsim-yeunja-tang Seung-Heon Hong (Wonkwang University) S 4 -3 (10: 00 -10: 30) Developmental research for Anti-hyperlipidemic herbal drug using SGMX In-Chan Seol (Daejeon University) S 4 -4 (10: 30 -11: 00) Herbal medicines in the prevention and treatment of osteoporosis Huayue Chen (Gifu University Graduate School of Medicine, Japan) S 4 -5 (11: 00 -11: 30) Development of anti-hepatofibrotic drug using an herbal formula, CGX Chang Gue Son (Daejeon University) S 4 -6 (11: 30 -12: 00) Drug development for asthma using mixed herbal medicine materials containing Inula flos Eunkyung Lee (Daegu Gyeongbuk Institute for Oriental Medicine Industry)
Symposium 5 : Drug Repositioning: Emerging Paradigm for New Drug Discovery Geumgang Hall Organizer : Sung Hoon Kim (Seoul National University) Chair : Sung Hoon Kim (Seoul National University) S 5 -1 (09: 00 -09: 30) Application of GPCR panel screening system into drug repositioning Tae Gyu Lee (NEWGEX, Inc. ) S 5 -2 (09: 30 -10: 00) Drug repositioning using literature analytics: the biovista platfrom Andreas Persidis (Biovista, Inc. , USA) Coffee Break (10: 00 -10: 20) S 5 -3 (10: 20 -10: 50) Knowledge-based drug repositioning Kyoohyoung Rho (Seoul National University) S 5 -4 (10: 50 -11: 20) Chemical genomic approach to drug repositioning Woo Ghil Lee (Korea Research Institute of Chemical Technology) S 5 -5 (11: 20 -11: 50) Drug reprofiling platform as a risk leverage strategy in drug discovery Akinori Mochizuki (Sosei Co. , Ltd. , Japan)
Symposium 6 : New Concepts in Pathophysiology and Therapeutics Guhmoongo Hall A Organizers : Uh Taek Oh (Seoul National University) Young Kee Shin (Seoul National University) Chair : Young Kee Shin (Seoul National University) S 6 -1 (13: 40 -14: 15) Novel therapeutic targets of liver cancer identified genome-wide approach Young Il Yeom (Korea Research Institute of Bioscience and Biotechnology) S 6 -2 (14: 15 -14: 50) Role of kupffer cells in vascular stress genes during trauma and sepsis Sun-Mee Lee (Sungkyunkwan University) Coffee Break (14: 50 -15: 10) S 6 -3 (15: 10 -15: 45) Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatits B virus-associated hepatocellular carcinoma Mee Ok Lee (Seoul National University) S 6 -4 (15: 45 -16: 20) Human papilloma virus E 6/E 7 si. RNA potentiates therapeutic effect of cisplatin in cervical squamous cell carcinma Young Kee Shin (Seoul National University)
Symposium 7 : Recent Issues of Toxicological Research in Pharmaceutical & Cosmetic Industry Guhmoongo Hall B Organizer : Hye-Young Oh (National Institute of Toxicological Research) Chairs : Dong-Sup Kim (National Institute of Toxicological Research) Hong-Ki Min (National Institute of Toxicological Research) S 7 -1 (13: 40 -14: 10) Alternatives to animal tests and safety evaluation for cosmetics Kyung-Hee Sohn (Immunotoxicology Division, National Institute of S 7 -2 (14: 10 -14: 40) Test approaches assessing safety for new drug using nanotechnology Min-Jung Cho (Toxicopathology Division, National Institute of Toxicological S 7 -3 (14: 40 -15: 10) Toxicological Research) Toxicogenomics as a tool for development and safety assessment of drugs: a regulatory aspect Ho-Sang Jeong (Molecular Pharmacology Division, National Institute of Toxicological Research) S 7 -4 (15: 10 -15: 40) Technical assistance in medical product development and regulatory sciences Young-Ju Choi (Biotechnological Development Assistance Division, National S 7 -5 (15: 40 -16: 10) Recent issues of endocrine disrupters in medicine and cosmetics Ki-Kyung Jung (Endocrine Toxicology Division, National Institute of S 7 -6 (16: 10 -16: 40) Current aspects in assessment of adverse drug reaction Ji Hye Ha (Risk Assessment Division, National Institute of Toxicological Research)
Symposium 8 : Recent Progress in the Strategy for Cancer Chemoprevention Guhmoongo Hall C Organizers : Young-Joon Surh (Seoul National University) Sang Kook Lee (Ewha Womans University) Chairs : Young-Nam Cha (Inha University) Thomas Kensler (Johns Hopkins University, USA) Session Introduction (13: 40 -13: 50) S 8 -1 (13: 50 -14: 20) Molecular targets for cancer chemoprevention Zigang Dong (University of Minnesota, USA) S 8 -2 (14: 20 -14: 45) Naturally occurring anti-inflammatory and antioxidative substances with cancer chemopreventive potential Young-Joon Surh (Seoul National University) S 8 -3 (14: 45 -15: 15) Chemical genetic approach to ubiquitin-proteasome biology: a novel strategy for chemoprevention and chemotherapy Kyung-Bo Kim (University of Kentucky, USA) S 8 -4 (15: 15 -15: 40) JNK 1 and JNK 2 as potential targets for chemoprevention of skin carcinogenesis Hong Seok Choi (Chosun University) S 8 -5 (15: 40 -16: 05) Step-up therapy for ulcerative colitis, but step-down therapy for colitic cancer prevention Ki-Baik Hahm (DMC Bundang Jesaeng Hospital) S 8 -6 (16: 05 -16: 30) Gene-environment interaction of breast cancer development and recurrence Dae Hee Kang (Seoul National University) Closing Remarks (16: 30 -16: 40)
Symposium 9 : Recent Trends of Drug Evaluation Hangang Hall Organizer : Chair : In Kyu Kim (Korea Food & Drug Administration) Bo Kyung Choi (Korea Food & Drug Administration) S 9 -1 (13: 40 -14: 10) What’s new in regulations on stability, specifications and test procedures of drugs? Young Lim Kim (Korea Food & Drug Administration) S 9 -2 (14: 10 -14: 40) KFDA’s approach to international harmonization review for drug safety and efficacy Su Jung Lee (Korea Food & Drug Administration) S 9 -3 (14: 40 -15: 10) Regulations on herbal medicinal products Jong Pill Lee (Korea Food & Drug Administration) S 9 -4 (15: 10 -15: 40) Regulations on hair loss prevention products Mi-Jeong Kim (Korea Food & Drug Administration) S 9 -5 (15: 40 -16: 10) Drug information standardization and strategies to support the development of medicines Dong Hee Lee (Korea Food & Drug Administration) S 9 -6 (16: 10 -16: 40) Regulations and evaluation on functional cosmetics Kyung Hun Son (Korea Food & Drug Administration)
Symposium 10 : Pharmaceutical Quality Assurance and Validation Geumgang Hall Organizers : Kong-Joo Lee (Ewha Womans University) Young Joo Kwon (Ewha Womans University) Chairs : Chung-Kyu Ryu (Ewha Wonams University) Sang Beom Han (Chung-Ang University) S 10 -1 (13: 40 -14: 20) Good manufacturing practice & quality control Sang-Hun Seo (Yuhan Corporation) S 10 -2 (14: 20 -15: 00) Overview of the validation Hee Kyun Lim (MSD Korea) Coffee Break (15: 00 -15: 10) S 10 -3 (15: 10 -15: 50) New GMP standards for medical products in Korea-validation, production and hygiene control, change control, inspection etc. Chang Yun Lee (Korea Food & Drug Administration)
Symposium 11 : Recent Progress in Biochemical Therapeutics Targeting Biomolecules Guhmoongo Hall A Organizer : Young-Soo Kim (Chungbuk National University) Chairs : Jeong Hwan Han (Sungkyunkwan University) Kyung Jae Kim (Samyook University) S 11 -1 (09: 00 -09: 30) Recent advances in computational methods for drug discovery Hwangseo Park (Sejong University) S 11 -2 (09: 30 -10: 00) An approach for the targeted delivery of si. RNA into human T cells Sang-Kyung Lee (Hanyang University) Coffee Break (10: 00 -10: 20) S 11 -3 (10: 20 -11: 10) TIMP-2 Putative integrin binding peptides that retain potent anti-angiogenic and anti-tumorigenic activity: potential novel cancer therapeutics William G. Stetler-Stevenson (National Institute of Health, USA) S 11 -4 (11: 10 -11: 40) Interactomics: modulation of specific intracellular signaling pathway by protein transduction Sang-Kyou Lee (Yonsei University)
Symposium 12 : Strategies for the Development of Novel Anti-diabetic Agents Guhmoongo Hall B Organizers : Nam Deuk Kim (Pusan National University) Jeong Min Kim (Green Cross Corp. ) Chairs : Jeong Min Kim (Green Cross Corp. ) Myung-Shik Lee (Samsung Medical Center) S 12 -1 (9: 00 -09: 35) Oxidative stress and inflammatory signals in adipose tissue of obesity Jae Bum Kim (Seoul National University) S 12 -2 (9: 35 -10: 10) Comparative proteomic approach for target/biomarker discovery in metabolic disease Tae Hoon Lee (SIGMOL, Inc. ) S 12 -3 (10: 10 -10: 45) Current status in the development of anti-diabetic agents: targeting ER stress and inflammation associated with lipid injury Myung-Shik Lee (Samsung Medical Center) S 12 -4 (10: 45 -11: 20) Development of potential dipeptidyl peptidase Ⅳ (DPP-Ⅳ) inhibitor Jin Hee Ahn (Korea Research Institute of Chemical Technology) S 12 -5 (11: 20 -11: 55) Development of a novel CB 1 receptor antagonist as an anti-diabetic agent Jeong Min Kim (Green Cross Corp. )
Symposium 13 : Korea-Japan Joint Symposium on Reactive Oxygen Species Guhmoongo Hall C Organizers : Hideo Utsumi (Kyushu University, Japan) Beom-Jin Lee (Kangwon National University) Chairs : Tetsuo Nagano (Tokyo University, Japan) Se-Young Chung (Kyunghee University) S 13 -1 (09: 00 -09: 30) Function of DJ-1, a causative gene product for familial Parkinson’s disease, and its therapeutic application to Parkinson’s disease Hiroyoshi Ariga (Hokkaido University, Japan) S 13 -2 (09: 00 -10: 00) Vitamin E, mechanism of transport and genetic disorder Akira Arai (University of Tokyo, Japan) S 13 -3 (10: 00 -10: 30) Development of molecular imaging of redox status in oxidative disease models Hideo Utsumi (Kyushu University, Japan) S 13 -4 (10: 30 -11: 00) Collagen-induced oxidation of SHP-2 promotes platelet aggregation Tong-Shin Chang (Ewha Womans University) S 13 -5 (11: 00 -11: 30) Redox regulation by the Nrf 2/ARE-driven antioxidant pathway Mi-Kyoung Kwak (Yeungnam University) S 13 -6 (11: 30 -12: 00) Cellular adaptive survival response to oxidative, nitrosative and inflammatory stress Young-Joon Surh (Seoul National University)
Symposium 14 : Strategies for Development of Products with Innovative Technology Hangang Hall Organizer : Young-Joon Park (Samil Pharm. Co. , Ltd) Chairs : Hyo Kyung Han (Chosun University) Sung-Up Choi (Samil Pharm. Co. , Ltd) S 14 -1 (09: 00 -09: 20) Itraconazole solubilized in cream formulation for topical delivery Jaehwi Lee (Chung-Ang University) S 14 -2 (09: 30 -09: 50) Development of self-assembled nanoparticles for targeted cancer therapy Jae Hyung Park (Kyung Hee University) S 14 -3 (10: 00 -10: 20) Comparative pharmacokinetic evaluation of controlled-and Immediate-release tablets containing simvastatin Jae-Kuk Ryu (Hanmi Pharm. Co. , Ltd. ) Coffee Break (10: 20 -10: 40) S 14 -4 (10: 40 -11: 00) Development of a new antidiabetic fixed-dose comgination drug using SR matrix and micro-film coating technologies Kwon-Yeon Weon (Handok Pharma. Co. , Ltd. ) S 14 -5 (11: 10 -11: 30) Regulatory evaluation of pharmaceuticals with innovative technology Hee-Sung Kim (Korea Food and Drug Administration) S 14 -6 (11: 40 -12: 00) The policies on “Incremetally Modified Drug” pricing Ha Tae Kil (Ministry for Health Welfare and Family Affairs)
Symposium 15 : Managed Care Pharmacy Issues for the Better Pharmaceutical Care Geumgang Hall Organizer : Hyun Taek Shin (Sookmyung Women's University) Chairs : Youn Sung Choo (LG Life Sciences Ltd. ) Eui Kyung Lee (Sookmyung Women's University) S 15 -1 (09: 00 -09: 40) Envisioning the roles of managed care pharmacy to maximize the value of pharmaceuticals in Korea Hyun Taek Shin (Sookmyung Women’s University) S 15 -2 (09: 40 -10: 20) Adjudication on multi-drug prescriptions and the strategies for solving the existing problems Yung Eob Choi (Health Insurance Review & Assessment Service) Coffee Break (10: 20 -10: 40) S 15 -3 (10: 40 -11: 20) Centralized DUR and prescription management: leveraging the US experience in other countries Robert Craig (Medco Health Solutions, Inc. , USA) S 15 -4 (11: 20 -12: 00) Computer-aided utilization management: improving pharmaceutical care William Wallace (Medco Health Solutions, Inc. , USA)
Symposium 16 : Current Issues in the Development and Regulation of Biologics Guhmoongo Hall A Organizer : Yeo-won Son (Korea Food and Drug Administration) Chair : Yeo-won Son (Korea Food and Drug Administration) S 16 -1 (14: 00 -14: 30) Recent trends in the development and licensing of the diagnostic DNA chip Jae Ok Kim (Korea Food and Drug Administration) S 16 -2 (14: 30 -15: 00) Considerations for special characteristics of cell theraphy products as drug Kwang Moon Lee (Korea Food and Drug Administration) S 16 -3 (15: 00 -15: 30) Recent trends and Korea’s cases in the development of gene therapy products Joung Min Choi (Korea Food and Drug Administration) Coffee Break (15: 30 -15: 45) S 16 -4 (15: 45 -16: 15) Regulatory perspective on biosimilars : quality issues Soo-Kyoung Suh (Korea Food and Drug Administration) S 16 -5 (16: 20 -16: 50) Regulatory perspectives on biosimilars : non-clinical/clinical issues Kyung Min Baek (Korea Food and Drug Administration)
Symposium 17 : Technologies for Production of Biological Therapeutics Guhmoongo Hall B Organizer : Duk Je Oh (Sejong University) Chairs : Phil K. Lee (Pharmaceutical Advisers LLC) Cheo Young Lee (5 T International Patent Law Firm) Duk Je Oh (Sejong University) S 17 -1 (14: 00 -14: 20) Case study: process development and c. GMP manufacturing of biologics at Celltrion Joo Ho Park (Celltrion Inc. ) S 17 -2 (14: 25 -14: 45) Overview on vaccine production technologies Kyung Dong Bae (Berna Biotech Korea) S 17 -3 (14: 50 -15: 10) Risk management to out-sourcing project with CMO Phil K. Lee (Pharmaceutical Advisers LLC) S 17 -4 (15: 15 -15: 35) Manufacturing issues of therapeutic antibody Heungrok Park (Isu Abxis Co. , Ltd. ) S 17 -5 (15: 40 -16: 00) Patent issues on biological products patent map about therapeutic antibodies Cheo Young Lee (5 T International Patent Law Firm) S 17 -6 (16: 25 -16: 45) Production and quality control of cell/gene therapy product Tissue Gene-CTM Jung Jong Cho (Kolon Life Science)
Symposium 18 : Current Status and Perspectives of Continuing Education for Physicians and Pharmacists Guhmoongo Hall C Organizers : 손의동(중앙대학교) 신현택 (숙명여자대학교) Chairs : 신현택 (숙명여자대학교) , 정명현 (연세대학교) S 18 -1 (14: 00 -14: 25) 의사 국가시험의 현황과 전망 정명현 (연대의대 이비인후과 교수, 국시원 의사시험위원장) S 18 -2 (14: 25 -14: 50) 의사 졸업 후 교육의 현황과 전망 이윤성 (서울대 의대 법의학과 교수, 의학교육학회 차기회장) S 18 -3 (14: 50 -15: 15) 의사의 평생교육의 현황과 전망 신양식 (연대의대 마취통증의학과, 대한의사협회 학술이사) Coffee Break (15: 15 -15: 30) S 18 -4 (15: 30 -15: 55) 약사 국가시험 현황과 개선방향 손의동 (중앙대학교 약학대학 학장, 국시원 약사시험위원) S 18 -5 (15: 55 -16: 20) 약사 졸업 후 평생교육(CE)의 현황과 발전방향 차도련 (대한약사회 학술이사) S 18 -6 (16: 20 -16: 45) 약사 졸업 후 전문수련과정의 현황과 발전방향 박경호 (서울대병원 약제부)
Symposium 19 : On Education and Research Outlook for Social Pharmacy in Korea Hangang Hall Organizer : Byong Hyon Han (Korea Health Industry Development Institute) Chair : Chong-Kook Kim (Seoul National University/Inje University) S 19 -1 (14: 00 -14: 35) Why social pharmacy needed? Byong Hyon Han (Korea Health Industry Development Institute) S 19 -2 (14: 35 -15: 10) Proposal of social pharmacy education in the six-year college of pharmacy program Eui Kyung Lee (Sookmyung Women’s University) Coffee Break (15: 10 -15: 25) S 19 -3 (15: 25 -16: 00) Social pharmacy : educational and research trends in Korea Kyeng Hee Kwon (Seoul National University) S 19 -4 (16: 00 -16: 35) Social pharmacy as an academic discipline Eun Cho (MSD Korea)
Symposium 20 : Drug Metabolism and Transport in Drug Discovery/Development Geumgang Hall Organizers : Chang Koo Shim (Seoul National University) Jae-Gook Shin (Inje University) Chairs : Chang Koo Shim (Seoul National University) Jae-Gook Shin (Inje University) S 20 -1 (14: 00 -14: 40) Integrating systems information on drug metabolism and pharmacokinetics: in vitro – in-vivo extrapolation to predict ADME and its interindividual variability Amin Rostami-Hodjegan (University of Sheffield, UK) S 20 -2 (14: 40 -15: 05) Drug metabolism in drug R&D: from molecular to clinical Hye Suk Lee (Wonkwang University) S 20 -3 (15: 05 -15: 30) Drug transport in drug R&D: from molecular to clinical Suk-Jae Chung (Seoul National University) Coffee Break (15: 30 -15: 40) S 20 -4 (15: 40 -16: 05) Drug interaction on drug metabolism and transport Im-Sook Song (Inje University) S 20 -5 (16: 05 -16: 05) Pharmacogenetics of drug disposition: consideration in drug R&D Jae-Gook Shin (Inje University) S 20 -6 (16: 05 -16: 30) DM/PK in drug R&D: Korean industry perspectives Hyun Joo Shim (Dong A Pharm. Co. , Ltd. ) S 20 -7 (16: 45 -17: 00) Drug metabolism/transport and drug interaction: regulatory perspectives of KFDA Kyung Won Seo (Korea Food and Drug Administration)
99cde005743301c47f8fc12053c0e653.ppt